NDC 57955-6030

Sciatic Nerve Formula

Aesculus Hippocastanum, Ammonium Muriaticum, Arsenicum Album, Belladonna, Capsicum Annuum, Causticum, Colchicum Autumnale, Colocynthis, Gnaphalium Polycephalum, Ignatia Amara, Magnesia Phosphoria, Rhus Toxicodendron

Sciatic Nerve Formula is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by King Bio Inc.. The primary component is Horse Chestnut; Ammonium Chloride; Arsenic Trioxide; Atropa Belladonna; Capsicum; Causticum; Colchicum Autumnale Bulb; Citrullus Colocynthis Fruit Pulp; Pseudognaphalium Obtusifolium; Strychnos Ignatii Seed; Magnesium Phosphate, Dibasic Trihydrate; Toxicodendron Pubescens Leaf.

Product ID57955-6030_3c806dbe-5051-43c1-b43f-8a4f6a1bbcc6
NDC57955-6030
Product TypeHuman Otc Drug
Proprietary NameSciatic Nerve Formula
Generic NameAesculus Hippocastanum, Ammonium Muriaticum, Arsenicum Album, Belladonna, Capsicum Annuum, Causticum, Colchicum Autumnale, Colocynthis, Gnaphalium Polycephalum, Ignatia Amara, Magnesia Phosphoria, Rhus Toxicodendron
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2013-10-31
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameKing Bio Inc.
Substance NameHORSE CHESTNUT; AMMONIUM CHLORIDE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAPSICUM; CAUSTICUM; COLCHICUM AUTUMNALE BULB; CITRULLUS COLOCYNTHIS FRUIT PULP; PSEUDOGNAPHALIUM OBTUSIFOLIUM; STRYCHNOS IGNATII SEED; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; TOXICODENDRON PUBESCENS LEAF
Active Ingredient Strength10 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 57955-6030-2

1 BOTTLE, SPRAY in 1 CARTON (57955-6030-2) > 59 mL in 1 BOTTLE, SPRAY
Marketing Start Date2019-02-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 57955-6030-2 [57955603002]

Sciatic Nerve Formula LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-10-31
Inactivation Date2020-01-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.